Discussions have focused on the underlying mechanism(s) for poor cancer prognosis, e.g. the chemotherapy insensitivity of cells with high levels of nuclear YB-1 expression may be due to upregulated expression of multidrug resistance-1 (MDR-1 [10]) and the ABC transporter MRP2 [27]. This evidence concerns the gene YBX1 and cancer.